Valacyclovir+Temovate Gel for the Treatment of Herpes Labialis
Completed
GlaxoSmithKline
Phase 2
2004-09-01
A randomized study comparing the combination of valacyclovir and temovate gel (clobetasol
gel) versus placebo for the treatment of recurrent herpes labialis (cold sores).
Valacyclovir+Temovate Gel for the Treatment of Herpes Labialis
Completed
University of Utah
Phase 2
2004-09-01
A randomized study comparing the combination of valacyclovir and temovate gel (clobetasol
gel) versus placebo for the treatment of recurrent herpes labialis (cold sores).
The purpose of this study is to determine the effect of short-term therapy using "VANOS
Cream," a super-potent topical steroid cream on skin barrier function in patients with atopic
dermatitis. This cream is already approved for this indication, but the investigators will
further examine its effects on the skin barrier. This cream is a novel formulation of
fluocinonide designed to enhance compliance with a cream base, but have the skin barrier
repair properties of an ointment.
The purpose of this study is to determine the effect of short-term therapy using "VANOS
Cream," a super-potent topical steroid cream on skin barrier function in patients with atopic
dermatitis. This cream is already approved for this indication, but the investigators will
further examine its effects on the skin barrier. This cream is a novel formulation of
fluocinonide designed to enhance compliance with a cream base, but have the skin barrier
repair properties of an ointment.
A Study Evaluating the Efficacy of Fluocinonide Cream 0.1% (Vanos) in Subjects With Atopic Dermatitis
Completed
Medicis Pharmaceutical Corporation
Phase 4
2009-03-01
The purpose of this research study is to better understand how fluocinonide cream 0.1%
(Vanos®) works when people use it to treat atopic dermatitis for just a few days.
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data.
The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free.
We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models.
By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice.
thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user.
Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Alerts Available With Subscription
Alerts are available for users with active subscriptions.
